back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2015-12-21 Tx date 2015-12-10 |
$BCT
BriaCell Therapeutics Corp. |
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$819.50
+5,000 vol $0.1639 each |
30,000 | |
| Filed 2015-12-07 Tx date 2015-06-01 |
$BCT
BriaCell Therapeutics Corp. |
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-07 Tx date 2015-12-04 |
$BCT
BriaCell Therapeutics Corp. |
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$81.60
+500 vol $0.1632 each |
500 | |
| Filed 2015-12-07 Tx date 2015-12-04 |
$BCT
BriaCell Therapeutics Corp. |
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$83.30
+500 vol $0.1666 each |
1,000 | |
| Filed 2015-12-07 Tx date 2015-12-04 |
$BCT
BriaCell Therapeutics Corp. |
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$751.05
+4,500 vol $0.1669 each |
5,500 | |
| Filed 2015-12-07 Tx date 2015-12-07 |
$BCT
BriaCell Therapeutics Corp. |
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$862.50
+5,000 vol $0.1725 each |
20,000 | |
| Filed 2015-12-07 Tx date 2015-12-07 |
$BCT
BriaCell Therapeutics Corp. |
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$861.50
+5,000 vol $0.1723 each |
25,000 | |
| Filed 2015-12-07 Tx date 2015-12-04 |
$BCT
BriaCell Therapeutics Corp. |
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$783.00
+4,500 vol $0.174 each |
10,000 | |
| Filed 2015-12-07 Tx date 2015-12-07 |
$BCT
BriaCell Therapeutics Corp. |
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$841.50
+5,000 vol $0.1683 each |
15,000 | |
| Filed 2015-11-05 Tx date 2015-06-01 |
$BCT
BriaCell Therapeutics Corp. |
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-11-05 Tx date 2015-11-04 |
$BCT
BriaCell Therapeutics Corp. |
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$255,000
+1,000,000 vol $0.255 each |
1,000,000 |